Literature DB >> 23825789

Symptomatic large bilateral adrenal metastases at presentation in small-cell lung cancer: a case report and review of the literature.

Navneet Singh1, Karan Madan, Ashutosh N Aggarwal, Ashim Das.   

Abstract

The adrenal gland is a common site for metastasis from lung cancer. Adrenal metastases are usually solitary, asymptomatic and diagnosed incidentally during staging of patients with lung cancer. Bilateral adrenal metastases at the time of diagnosis are seen in 3% of lung cancer patients. Large symptomatic bilateral adrenal metastases at presentation are extremely rare and those occurring in the setting of small cell lung cancer (SCLC) have not been reported previously. Herein we describe a 46-year old male patient with SCLC who was symptomatic from large bilateral adrenal metastases at presentation. The patient was successfully treated with conventional platinum based chemotherapy and had no complications related to the large adrenal masses (intratumoral hemorrhage or adrenal insufficiency) either at presentation or subsequently during treatment and follow up.

Entities:  

Keywords:  Lung cancer; adrenal gland; mass; metastasis

Year:  2013        PMID: 23825789      PMCID: PMC3698258          DOI: 10.3978/j.issn.2072-1439.2011.09.05

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  9 in total

1.  Metastases in carcinoma; analysis of 1000 autopsied cases.

Authors:  H L ABRAMS; R SPIRO; N GOLDSTEIN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

2.  Sensitivity and specificity of computed tomography for the detection of adrenal metastatic lesions among 91 autopsied lung cancer patients.

Authors:  P Allard; B C Yankaskas; R H Fletcher; L A Parker; R A Halvorsen
Journal:  Cancer       Date:  1990-08-01       Impact factor: 6.860

Review 3.  Adrenal incidentaloma.

Authors:  L M Brunt; J F Moley
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

4.  Metastatic non-small-cell lung carcinoma successfully treated with pre-operative chemotherapy and bilateral adrenalectomy.

Authors:  Alberto Muñoz; Guillermo López-Vivanco; Joan-Manel Mañé; Ricardo Fernández; Javier Díaz-Aguirregoitia; Mónica Saiz; Ramón Barceló
Journal:  Jpn J Clin Oncol       Date:  2006-10-27       Impact factor: 3.019

5.  Adrenal insufficiency as a presenting manifestation of nonsmall cell lung cancer.

Authors:  Khalid Mohammad; Ruxana T Sadikot
Journal:  South Med J       Date:  2009-06       Impact factor: 0.954

Review 6.  Surgical management of adrenal metastases from lung cancer.

Authors:  A L Beitler; J D Urschel; S R Velagapudi; H Takita
Journal:  J Surg Oncol       Date:  1998-09       Impact factor: 3.454

7.  Massive retroperitoneal adrenal hemorrhage secondary to lung cancer metastasis treated by adrenal artery embolization.

Authors:  Santhosh Ambika; Andrea Melton; David Lee; Paul J Hesketh
Journal:  Clin Lung Cancer       Date:  2009-09       Impact factor: 4.785

8.  Large adrenal metastasis in non-small cell lung carcinoma. Case report and literature review.

Authors:  Stavros Charalambous; Efrosyni Mylonaki; Asterios Fotas; Athanasios G Papatsoris; Athanasios Papathanasiou; Argyrios Triantafyllidis; Vasilios Rombis; Stravros Touloupidis
Journal:  Tumori       Date:  2008 Jan-Feb

9.  Large bilateral adrenal metastases in non-small cell lung cancer.

Authors:  Charisios Karanikiotis; Apostolos Anto Tentes; Sotirios Markakidis; Konstantinos Vafiadis
Journal:  World J Surg Oncol       Date:  2004-11-13       Impact factor: 2.754

  9 in total
  2 in total

1.  Laryngeal metastasis from lung cancer.

Authors:  Umasankar Kalai; Karan Madan; Deepali Jain; Anant Mohan; Randeep Guleria
Journal:  Lung India       Date:  2015 May-Jun

2.  Different distant metastasis patterns based on tumor size could be found in extensive-stage small cell lung cancer patients: a large, population-based SEER study.

Authors:  Jia Li; Feng Liu; Haining Yu; Chenglong Zhao; Zhenxiang Li; Haiyong Wang
Journal:  PeerJ       Date:  2019-12-03       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.